An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …
…, DA Lynch, AG Nicholson, CJ Ryerson… - American journal of …, 2013 - atsjournals.org
Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS)
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline
…, JL Myers, L Richeldi, CJ Ryerson… - American journal of …, 2018 - atsjournals.org
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline
…, JL Myers, AG Nicholson, CJ Ryerson… - American Journal of …, 2022 - atsjournals.org
… Ryerson … Ryerson … Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer
DJ, et al.; American Thoracic Society, European Respiratory Society, Japanese Respiratory …
DJ, et al.; American Thoracic Society, European Respiratory Society, Japanese Respiratory …
The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society
GD Rubin, CJ Ryerson, LB Haramati, N Sverzellati… - Radiology, 2020 - pubs.rsna.org
With more than 900 000 confirmed cases worldwide and nearly 50 000 deaths during the
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte… - American journal of …, 2016 - atsjournals.org
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …
significant, respiratory deterioration of unidentifiable cause. The objective of this …
A multidimensional index and staging system for idiopathic pulmonary fibrosis
B Ley, CJ Ryerson, E Vittinghoff, JH Ryu… - Annals of internal …, 2012 - acpjournals.org
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an
overall poor prognosis. A simple-to-use staging system for IPF may improve prognostication…
overall poor prognosis. A simple-to-use staging system for IPF may improve prognostication…
Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline
G Raghu, M Remy-Jardin, CJ Ryerson… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …
represents a collaborative effort among the American Thoracic Society, Japanese …
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
This Review provides an updated approach to the diagnosis of idiopathic pulmonary fibrosis
(IPF), based on a systematic search of the medical literature and the expert opinion of …
(IPF), based on a systematic search of the medical literature and the expert opinion of …
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society
…, T Johkoh, N Sverzellati, CJ Ryerson… - The lancet Respiratory …, 2020 - thelancet.com
The term interstitial lung abnormalities refers to specific CT findings that are potentially
compatible with interstitial lung disease in patients without clinical suspicion of the disease. …
compatible with interstitial lung disease in patients without clinical suspicion of the disease. …
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
…, TM Maher, A Tzouvelekis, CJ Ryerson - Pharmacology & …, 2021 - Elsevier
… Ryerson i … Ryerson reports grant funding and personal fees from Boehringer Ingelheim and
Hoffmann-La Roche, … MY Armanios, CJ JL, JD Cogan, JK Alder, RG Ingersoll, C. Markin, et al. …
Hoffmann-La Roche, … MY Armanios, CJ JL, JD Cogan, JK Alder, RG Ingersoll, C. Markin, et al. …